Intrinsic Value

NeuroSense Therapeutics Ltd. (NRSN)

$1.29

+0.01 (+0.78%)

Enterprise Value -
Net Debt -2.54
Equity Value -
Shares Outstanding 13.64
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt